Opendata, web and dolomites

EVPRO SIGNED

EVPRO - Development of Extracellular Vesicles loaded hydrogel coatings with immunomodulatory activity for Promoted Regenerative Osseointegration of revision endoprosthesis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EVPRO project word cloud

Explore the words cloud of the EVPRO project. It provides you a very rough idea of what is the project "EVPRO" about.

drugs    suppress    inflammation    integration    successful    protection    osseointegration    setting    regulated    site    pro    coating    store    absorbed    steroid    reactions    extracellular    anti    direct    disease    treat    successfully    implant    regenerative    progression    evpro    osteogenic    gmp    difficult    reaction    select    refractory    local    conventional    prosthesis    introduce    versus    overcomes    rejection    status    micropores    function    individual    bed    revision    host    medically    enhanced    regeneration    establishing    mostly    titan    stem    osteoarticular    msc    affix    tio2    severe    biodegradable    cell    technologies    safe    microfluidic    evs    hydrogel    effect    exert    surface    mesenchymal    uniform    surgical    inflammatory    resolution    human    conformed    humans    physical    post    shaft    clinical    self    tissue    graft    endoprosthesis    release    implantation    patients    proof    confinement    vesicles    symptoms    proximity    multidisciplinary    smart    trials    matrix    purify   

Project "EVPRO" data sheet

The following table provides information about the project.

Coordinator
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. 

Organization address
address: HANSASTRASSE 27C
city: MUNCHEN
postcode: 80686
website: www.fraunhofer.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 5˙799˙088 €
 EC max contribution 5˙799˙088 € (100%)
 Programme 1. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-NMBP-TR-IND-2018
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. DE (MUNCHEN) coordinator 865˙646.00
2    UNIVERSITAETSKLINIKUM ESSEN DE (ESSEN) participant 603˙250.00
3    DUBLIN CITY UNIVERSITY IE (DUBLIN) participant 569˙070.00
4    DWI LEIBNIZ-INSTITUT FUR INTERAKTIVE MATERIALIEN EV DE (AACHEN) participant 526˙080.00
5    MEOTEC GMBH & CO KG DE (AACHEN) participant 511˙250.00
6    UNIVERSITEIT MAASTRICHT NL (MAASTRICHT) participant 509˙363.00
7    POLITECNICO DI TORINO IT (TORINO) participant 500˙000.00
8    UNIVERSITAETSKLINIKUM KNAPPSCHAFTSKRANKENHAUS BOCHUM GMBH DE (BOCHUM) participant 470˙376.00
9    THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN IE (DUBLIN) participant 438˙327.00
10    LONZA NETHERLANDS BV NL (MAASTRICHT) participant 411˙975.00
11    STRYKER EUROPEAN OPERATIONS BV NL (AMSTERDAM) participant 393˙750.00

Map

 Project objective

Revision endoprosthesis are mostly associated with post-surgical physical symptoms that can lead to long-term confinement to bed and in severe cases to implant rejection. Severe inflammatory reactions in the endoprosthesis shaft can occur due to a previous long-term prosthesis. Medically managing the inflammation process is challenging as it is difficult to introduce drugs to the site of inflammation after implantation of the revision endoprosthesis. EVPRO overcomes this problem by using human mesenchymal stem cell derived extracellular vesicles (MSC-EVs) which are known to suppress inflammatory reaction in humans, exert pro-regenerative effects in osteogenic setting and successfully treat patients with steroid-refractory graft-versus-host disease. In this project the MSC-EVs will be applied in direct physical proximity to the site of inflammation and will therefore affix on the implant surface to deliver their anti-inflammatory and regenerative effect in response to the local inflammation status. This will be achieved by safe integration of the MSC-EVs in a smart biodegradable hydrogel that is absorbed into the micropores of a TiO2 coating on the surface of conventional titan endoprosthesis. EVPRO enables the progression of each individual technology, along with EVPRO system level integration developments, into pre-clinical trials, this means in detail, the development of a GMP conformed large scale production of MSC-EVs, the establishing of an uniform method to purify and select the most potential MSC-EVs with a microfluidic system and the design of a self-regulated hydrogel as protection matrix of MSC-EVs with the function to store and release MSC-EVs in response to the inflammation status, The EVPRO project is an integration of multidisciplinary post-proof of concept technologies which enables the successful resolution of the enhanced osseointegration of endoprosthesis for osteoarticular tissue regeneration.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EVPRO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EVPRO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.3.;H2020-EU.2.1.2.)

NanoSolveIT (2019)

Innovative Nanoinformatics models and tools: towards a Solid, verified and Integrated Approach to Predictive (eco)Toxicology (NanoSolveIT)

Read More  

SUSNANOFAB (2020)

INTEGRATED EU STRATEGY, SERVICES AND INTERNATIONAL COORDINATION ACTIVITIES FOR THE PROMOTION OF COMPETITIVE AND SUSTAINABLE NANOFABRICATION INDUSTRY

Read More  

NanoPAT (2020)

Process Analytical Technologies for Industrial Nanoparticle Production

Read More